| 2005 |
SLC6A15 (SBAT1) encodes a Na+-coupled transporter with strong preference for branched-chain amino acids (leucine, isoleucine, valine) and methionine (K0.5 80-160 µM), excluding aromatic or charged amino acids, β-amino acids, glycine, and GABA; transport is highly temperature-dependent (Q10=9) and inhibited at acidic pH; PKC activation reduces the plasma-membrane population of SBAT1 protein. |
Xenopus oocyte expression system with radiolabeled substrate uptake assays and PKC activation experiments |
Biochemical and biophysical research communications |
High |
16226721
|
| 2007 |
Deletion of SLC6A15 (v7-3) in mice causes 15% and 40% reductions in sodium-dependent proline and leucine uptake into cortical synaptosomes, respectively, establishing SLC6A15 as a contributor to synaptosomal neutral amino acid transport in vivo. |
V7-3 knockout mice with synaptosomal amino acid uptake assays |
Brain research |
High |
17931606
|
| 2013 |
SLC6A15 knockout mice show attenuated reduction of food intake and lower neuronal activation in the ventromedial hypothalamic nucleus (VMH) in response to intracerebroventricular leucine, demonstrating that SLC6A15 mediates leucine's anorexigenic effect in the brain. |
Slc6a15 KO mice with leucine injection, food intake measurement, and c-Fos immunohistochemistry in VMH |
PloS one |
High |
23505546 24023709
|
| 2013 |
SLC6A15 protein (B0AT2) is localized predominantly to neurons (including GABAergic neurons and spinal cord motor neurons), with additional expression in astrocytes near ventricles and in choroid plexus epithelial cells (co-localizing with cytokeratin and diazepam binding inhibitor). |
Immunohistochemistry and in situ hybridization on mouse CNS tissue; co-localization with cell-type markers |
PloS one |
Medium |
23505546
|
| 2015 |
Loss of SLC6A15 in mice reduces hippocampal tissue levels of proline and other neutral amino acids, decreases overall tissue glutamate and glutamine, yet increases basal extracellular glutamate tone; conversely, hippocampal SLC6A15 overexpression increases glutamate/glutamine tissue concentrations, linking SLC6A15 transport activity to glutamatergic neurochemistry. |
Slc6a15 KO mice and virus-mediated hippocampal overexpression with HPLC/NMR neurochemistry and in vivo microdialysis |
Journal of psychiatric research |
High |
26228428
|
| 2015 |
SLC6A15 overexpression in the hippocampus increases anxiety-like behavior basally, while knockout reduces anxiety and depressive-like behavior after chronic social stress; GluR1 (AMPA receptor subunit) expression in the dentate gyrus is regulated by Slc6a15, suggesting glutamatergic modulation as a downstream mechanism. |
Slc6a15 KO mice and virus-mediated hippocampal overexpression with behavioral testing and Western blot for GluR1/GluR2/NR1 |
Stress (Amsterdam, Netherlands) |
Medium |
26585320
|
| 2013 |
Two rare non-synonymous coding variants in SLC6A15 significantly increase maximal 3H-proline uptake compared to wild-type sequence, demonstrating that specific amino acid changes alter transporter activity. |
Cellular uptake assay with 3H-proline in cells expressing variant SLC6A15 constructs |
PloS one |
Medium |
23874702
|
| 2017 |
Selective reduction of Slc6a15 in nucleus accumbens D2-medium spiny neurons (using Cre-inducible virus with D2-Cre or A2A-Cre mice) causes enhanced susceptibility to subthreshold social defeat stress, while restoration of Slc6a15 expression in D2-neurons prevents social avoidance after chronic social defeat stress, placing SLC6A15 in NAc D2-neurons as a regulator of stress susceptibility. |
Cre-inducible viral knockdown/overexpression in D2-Cre and A2A-Cre mice; social defeat stress paradigm with social interaction readout |
The Journal of neuroscience |
High |
28576941
|
| 2020 |
Loss of SLC6A15 in primary hippocampal neurons reduces glutamate release probability at glutamatergic synapses, increases mitochondrial function, elevates GSH/GSSG redox ratio, and improves neurite outgrowth, demonstrating that SLC6A15 controls neutral amino acid concentrations that affect mitochondrial activity, synaptic function, and neuronal structure. |
Slc6a15-KO hippocampal neurons with proteomics, electrophysiology (release probability), Seahorse mitochondrial assay, glutathione assay, and neurite morphometry |
The European journal of neuroscience |
Medium |
33007132
|
| 2025 |
SLC6A15 (B0AT2) transports phenylalanine into melanocytes, and its knockdown reduces intracellular phenylalanine levels, decreases melanin synthesis, downregulates MITF, TYR, and DCT expression, and abrogates UVB-induced pigmentation increase; UVB exposure transcriptionally upregulates SLC6A15. |
siRNA knockdown in MNT1 cells and primary melanocytes; Fontana-Masson staining; tyrosinase activity assay; intracellular phenylalanine measurement; RT-qPCR |
Journal of photochemistry and photobiology. B, Biology |
Medium |
41352278
|
| 2025 |
First selective inhibitors of B0AT2/SLC6A15 were identified by HTS of 200,000 compounds using a 3H-proline uptake assay; a 1,5-benzodiazepine series inhibits SLC6A15 with IC50 ~250 nM in SLC6A15-overexpressing HEK293 cells and primary neurons, with no detectable inhibition of SERT, DAT, GAT1, or NTT4/SLC6A17; inhibitor treatment dose-dependently stimulates neurite outgrowth in primary neurons. |
High-throughput 3H-proline uptake assay; selectivity counter-screens vs. related SLC6 transporters; neurite outgrowth assay in primary hippocampal neurons |
bioRxivpreprint |
Medium |
bio_10.1101_2025.03.25.645215
|
| 2000 |
Human SLC6A15 (v7-3) encodes a protein with 12 predicted transmembrane domains, intracellular N- and C-terminal domains, large extracellular loops between TM3-4 and TM7-8, and N-linked glycosylation sites; when expressed with an epitope tag, v7-3 localizes to the cell surface, in contrast to the related NTT5 which is predominantly intracellular. |
Epitope-tagged transient transfection and subcellular localization by immunofluorescence |
Genomics |
Low |
11112352
|